60 Degrees Pharmaceuticals Updates ATM Program, Discloses $1.39M in Prior Sales and $1.3M Remaining Capacity
SXTP has more than doubled off its 52-week low of $1.36.
Summary
60 Degrees Pharmaceuticals updated its At-The-Market (ATM) offering, revealing it has already sold $1.39 million in stock and has an additional $1.3 million available to sell, representing substantial potential dilution for the micro-cap company.
Key Events · Financing and Capital Events · SXTP
-
ATM Program Update
The company amended its At-The-Market (ATM) offering program, allowing it to sell up to an additional $1,308,000 in common stock from time to time through H.C. Wainwright & Co., LLC.
-
Prior Share Sales Disclosed
60 Degrees Pharmaceuticals disclosed that it has already sold 555,593 shares under the ATM program for aggregate gross proceeds of $1,396,091 as of the date of this prospectus supplement.
-
Capital Raise Context
This capital raise follows the company's 1-for-4 reverse stock split on January 20, 2026, and its recent regaining of Nasdaq compliance on February 12, 2026, after receiving a delisting notice in January 2026.
Analysis · SXTP · Life Sciences
This filing updates an existing At-The-Market (ATM) offering program, revealing that 60 Degrees Pharmaceuticals has already sold $1.39 million worth of common stock and has authorized an additional $1.308 million for future sales. For a company with a market capitalization of approximately $3.2 million, these amounts represent significant potential dilution. The capital raised is crucial for the company, especially following its recent reverse stock split and successful efforts to regain Nasdaq compliance, indicating an ongoing need for operational funding.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SXTP was trading at $2.96 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $1.36 to $17.68. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.